E. Zborowska

发表

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability.

K. Kinzler, B. Vogelstein, L. Myeroff, 1995, Science.

Role of α5β1 integrin in determining malignant properties of colon carcinoma cells

Luzhe Sun, J. Willson, M. Brattain, 1997 .

Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells

J. Willson, Xiao-Fan Wang, M. Brattain, 1994 .

Control of Type II Transforming Growth Factor-β Receptor Expression by Integrin Ligation*

Luzhe Sun, J. Willson, L. Sun, 1999, The Journal of Biological Chemistry.

Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells.

J. Willson, X. F. Wang, L. Sun, 1994, The Journal of biological chemistry.

A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.

J. Willson, C. Arteaga, M. Brattain, 1998, International journal of oncology.

Topotecan increases topoisomerase IIalpha levels and sensitivity to treatment with etoposide in schedule-dependent process.

C. Whitacre, N. Berger, E. Zborowska, 1997, Cancer research.

The role of transforming growth factor alpha in determining growth factor independence.

N. Sergina, J. Willson, B. Ziober, 2003, Cancer research.

Detection of poly(ADP-ribose) polymerase cleavage in response to treatment with topoisomerase I inhibitors: a potential surrogate end point to assess treatment effectiveness.

J. Willson, C. Whitacre, N. Berger, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNU.

J. Willson, S. Markowitz, S. Gerson, 1997, Cancer Research.

Synergistic efficacy of O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone.

J. Willson, S. Gerson, E. Zborowska, 1993, Biochemical pharmacology.

Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.

Jing Wang, J. Willson, J. Hauser, 2006, Cancer research.

Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.

J. Willson, M. Brattain, J. Foster, 1999, Cancer research.

The Role of Transforming Growth Factor α in Determining Growth Factor Independence

N. Sergina, J. Willson, B. Ziober, 2003 .

Autocrine Transforming Growth Factor α Provides a Growth Advantage to Malignant Cells by Facilitating Re-entry into the Cell Cycle from Suboptimal Growth States*

J. Willson, M. Brattain, Degeng Wang, 1998, The Journal of Biological Chemistry.

Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells (*)

Luzhe Sun, L. Myeroff, J. Willson, 1995, The Journal of Biological Chemistry.

Expression of transforming growth factor‐β receptor type II and tumorigenicity in human breast adenocarcinoma MCF‐7 cells

J. Willson, M. Brattain, H. Soule, 1998 .

Reduced Expression of Transforming Growth Factor β Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma Cells*

Luzhe Sun, J. Willson, M. Brattain, 1996, The Journal of Biological Chemistry.

Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.

J. Willson, M. Brattain, H. Soule, 1998, Journal of cellular physiology.

Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.

J. Willson, N. Berger, E. Zborowska, 1994, Cancer research.

Reorganization of ErbB Family and Cell Survival Signaling after Knock-down of ErbB2 in Colon Cancer Cells*

N. Sergina, J. Willson, J. Hauser, 2005, Journal of Biological Chemistry.

The Role of Transforming Growth Factor in Determining Growth Factor Independence

N. Sergina, J. Willson, B. Ziober, 2003 .

Role of alpha 5 beta 1 integrin in determining malignant properties of colon carcinoma cells.

J. Willson, L. Sun, M. Brattain, 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.